Hospitalization

15 drugs in development·11 companies·2 clinical trials

Drug Pipeline by Phase

Approved(13)

Drug	Company
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
candesartan cilexetil	Aptinyx Inc. (APTX)
Jardiance	ELI LILLY & Co (LLY)
Jardiance®	ELI LILLY & Co (LLY)
letairis	GILEAD SCIENCES, INC. (GILD)
macitentan	Mylan II B.V. (MYL)
multaq	Sanofi (SNY)
paxlovid	PFIZER INC (PFE)
spironolactone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
valsartan	Mylan II B.V. (MYL)
VASCEPA (VAZKEPA in EU)	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA)	AMARIN CORP PLCUK (AMRN)
Verquvo	Merck & Co., Inc. (MRK)

Phase 1(2)

Drug	Company
furoscix	scPharmaceuticals Inc. (SCPH)
scp-111	scPharmaceuticals Inc. (SCPH)

BioSniper tracks 15 drugs in development for Hospitalization across 11 companies.

There are 2 clinical trials targeting Hospitalization tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.